Innovotech IncTSXV:IOT
- LAST PRICE0.1750
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1600/ 10
- Ask / Lots0.1900/ 70
- Open / Previous Close--- / 0.1750
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Nov 19, 2024
Innovotech Reports Results For Its Third Quarter And Nine Months Ended 30 September 2024, from 5:25PM ET on Tuesday Nov 19, 2024 by Dow Jones
5:25PM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 5, 2024
Innovotech Inc. Closes Over-subscribed Private Placement and Completes the Acquisition of Keystone Labs Inc., from 4:32PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:32PM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 30, 2024
Innovotech Inc. Announces Update to Keystone Acquisition and Private Placement, from 5:32PM ET on Wednesday Oct 30, 2024 by Dow Jones
5:32PM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Innovotech Inc | 7.2M | -18.7x | --- |
Principal Technologies Inc | 5.9M | -2.1x | --- |
Appili Therapeutics Inc | 4.2M | -1.2x | --- |
Willow Biosciences Inc | 11.5M | -1.3x | --- |
Marvel Biosciences Corp | 7.6M | -3.2x | --- |
XORTX Therapeutics Inc | 5.5M | -37.3x | --- |
Company Information
Innovotech Inc. is a Canadian biotechnology company. The Company is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. It also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.
Contact Information
- Headquarters
- 2011 94 St NW Suite 101EDMONTON, AB, Canada T6N 1H1
- Phone
- 780-448-0585
- Fax
- 780-424-0941
Executives
- Independent Chairman of the Board, Company Secretary
- James Timourian
- Chief Executive Officer, Director
- Craig Milne
- Chief Financial Officer
- Bernard Grobbelaar
- Director
- Julienne Wright
- Independent Director
- Karen Farkas
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.2M |
|---|---|
Revenue (TTM) | $1.2M |
Shares Outstanding | 40.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.32 |
EPS | $-0.01 |
Book Value | $0.02 |
P/E Ratio | -18.7x |
Price/Sales (TTM) | 5.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -39.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
